Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Significance of the Methylated Cytosine-Phosphate-Guanine Sites of Protocadherin-10 Promoter for Evaluating the Prognosis of Gastric Cancer

26 Jun 2014

Abstract excerpt

BACKGROUND: Protocadherin-10 (PCDH10) has been identified as a tumor suppressor gene in multiple carcinomas. In this study, we intended to elucidate the clinical applicability of the methylation of CpG sites of PCDH10 promoter for prognostic prediction in gastric cancer (GC). STUDY DESIGN: Qualitative and quantitative detections of PCDH10 promoter methylation were performed with methylation-specific polymerase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Epigenetics and DNA Methylation
Share to Wnt/β-catenin signaling in development and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25260683
DOI: 10.1016/j.jamcollsurg.2014.06.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Significance of the Methylated Cytosine-Phosphate-Guanine Sites of Protocadherin-10 Promoter for Evaluating the Prognosis of Gastric CancerPMID 25260683Read ↗

Methylation of Protocadherin 10, a Novel Tumor Suppressor, Is Associated With Poor Prognosis in Patients With Gastric CancerSemantic proximity Read ↗

Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosisSemantic proximity Read ↗

Bioinformatics study of PCDHB6 as a prognostic marker for gastric cancerSemantic proximity Read ↗

DNA Methylation Signatures Associated With Prognosis of Gastric CancerSemantic proximity Read ↗

E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1Semantic proximity Read ↗

DNA methylation signatures associated with prognosis of gastric cancerSemantic proximity Read ↗

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphomaSemantic proximity Read ↗

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patientsSemantic proximity Read ↗

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinomaSemantic proximity Read ↗

SFRP2 and RPRM as methylation based serum biomarkers for the detection of gastric cancerSemantic proximity Read ↗

Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder CancerSemantic proximity Read ↗

Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.